Since its inception in 1984, Daffodil Group, initially focused on Ethambutol, transitioned into a leading manufacturer of citrate derivatives by 1994, with a value over $25 million. It became a key supplier in pharmaceuticals, food additives, and chemicals, employing over 200 people in Gujarat, India.
Expanding into the U.S. in 2008, it established Daffocitra in 2014 to distribute products across the U.S., from Los Angeles to New York. Committed to quality and integrity, Daffodil founded Daffocare Labs in 2016, an FDA-approved and NABL-accredited R&D and testing lab for various industries, led by Mrs. Setu Patel.